HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
Clinical trials for HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES trials appear
Sign up with your email to follow new studies for HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves may help deliver cancer drugs to the brain
Disease control CompletedThis study tested whether a device that uses focused ultrasound can safely and temporarily open the blood-brain barrier in people with HER2-positive breast cancer that has spread to the brain. Eight participants received the procedure, and researchers checked for side effects and…
Matched conditions: HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
Phase: NA • Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Promising drug targets breast cancer in the brain
Disease control CompletedThis study tested a drug called neratinib, alone or with other medicines, in 140 people with HER2-positive breast cancer that spread to the brain. The goal was to see if the drug could shrink or stabilize brain tumors. Results help doctors understand how well this treatment works…
Matched conditions: HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC